The Impact of AI in R&D
AI is a hot topic in biotech, but how much is real and how much is fantasy? Join experts from Digitalis Ventures, Alnylam Pharmaceutical and Luminaries Forge as they discuss how AI is changing Clinical Research today and how to prepare for tomorrow.
![](/sites/default/files/2023-06/3c6a817c-afbe-47b4-b7f6-1b5977c34501.png)
Jacob Oppenheim
Entrepreneur-in-Residence
Digitalis Ventures
![](/sites/default/files/2024-05/6.Murtaza%20Cherawala%401x_0.png)
Murtaza Cherawala
Sr. Director of Data Management and Artificial Intelligence
Alnylam Pharmaceuticals
![](/sites/default/files/2024-05/8.Nate%20McBride%402x.png)
Nate McBride
Senior Vice President of IT
Xilio
![](/sites/default/files/2024-05/9.Catherine%20Hall%402x.png)
Cat Hall
Head of GXP Quality Assurance
Egnyte